Evaluation of bovine spongiform encephalopathy risk via the use of materials of bovine origin in or during the manufacture of vaccines

Current version

PDF iconPublic statement

Reference number CPMP/BWP/476/01
Published 28/02/2001
Keywords Bovine spongiform encephalopathy (BSE), risk, vaccine
Description This document adresses the safety of the use of bovine-origin materials in vaccines. It concludes that the risk of BSE contamination of vaccines used within the European Union is extremely low thanks to the safety measures being taken.

Related content

How useful was this page?

Add your rating